Surawicz, C.M., et al. (2013) Guidelines for Diagnosis, Treatment, and Prevention of Clostridium Difficile Infections. The American Journal of Gastroenterology, 108, 478-498.

has been cited by the following article:

• TITLE: Fecal Microbiota Transplantation for Fibromyalgia: A Case Report and Review of the Literature

  AUTHORS: T. Thurm, J. N. Ablin, D. Buskila, N. Maharshak

  KEYWORDS: Microbiota, Microbiome, Irritable Bowel Syndrome, Functional Disorders, Dysbiosis, Chronic Fatigue Syndrome

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.7 No.4, April 28, 2017

  ABSTRACT: A 58-year-old patient diagnosed with fibromyalgia, irritable bowel syndrome (IBS) and chronic fatigue syndrome (CFS), non-responsive to variety of treatments over the years, suffered from significant social and occupational disabilities. The patient was interested in fecal microbiota transplantation (FMT), but given that FMT is not approved for these indications, he used an online protocol for FMT screening and preparation and self-instilled the filtrate using an enema 6 times. FMT resulted in a gradual improvement of symptoms and 9 months after the last treatment, the patient reported full recovery of symptoms, going back to work at full time employment. Improvement of symptoms was associated with major alterations of the enteric microbiota, according to next generation sequencing analysis performed before the first FMT and after the last FMT. Most prominent alterations at the genus level included a decrease in fecal Streptococcus proportion from 26.39% to 0.15% and an increase in Bifidobacterium from 0% to 5.23%. This case is added to several additional case reports that demonstrated the effectivity of FMT in these functional disorders that are lacking an otherwise good medical therapeutic intervention. We conclude that randomized controlled trials are required to ground FMT as a possible therapy for these difficult-to-treat conditions.